(Q34551484)

3 August 2017

1 reference

title

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management (English)

1 reference

3 August 2017

Peter M Haddad

1

1 reference

PubMed ID

15456328

3 August 2017

Angelika Wieck

series ordinal

2

1 reference

3 August 2017

1 January 2004

1 reference

3 August 2017

1 reference

3 August 2017

64

1 reference

3 August 2017

20

1 reference

3 August 2017

2291-2314

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464200-00003

3 August 2017

0 references

cites work

2 Neuroendocrine effects of psychotropic drugs

1 reference

12 December 2020

The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations

1 reference

12 December 2020

Antipsychotic drug-induced hyperprolactinemia: clinical implications

1 reference

12 December 2020

Increased serum prolactin levels during phenothiazine and butyrophenone treatment of six postpartum women

1 reference

12 December 2020

Aripiprazole: profile on efficacy and safety

1 reference

12 December 2020

Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism

1 reference

12 December 2020

Assays for prolactin: guidelines for the provision of a clinical biochemistry service

1 reference

12 December 2020

Serum prolactin levels in unmedicated schizophrenic patients.

1 reference

12 December 2020

Galactorrhea: subjective response by schizophrenic patients

1 reference

12 December 2020

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

1 reference

12 December 2020

Abnormal prolactin response to haloperidol challenge in men with schizophrenia.

1 reference

12 December 2020

Operating characteristics of the hypothalamo-pituitary-gonadal axis in men: circadian, ultradian, and pulsatile release of prolactin and its temporal coupling with luteinizing hormone

1 reference

12 December 2020

Drug and alcohol problems among individuals with severe mental illness in south London

1 reference

12 December 2020

Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test

1 reference

12 December 2020

Hyperdopaminergia in schizophreniform psychosis: a chronobiological study

1 reference

12 December 2020

The 24-hour profile of plasma prolactin in men with major endogenous depressive illness.

1 reference

12 December 2020

1 reference

12 December 2020

The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia

1 reference

12 December 2020

Vertebral body bone mineral content in hyperprolactinemic women

1 reference

12 December 2020

Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine?

1 reference

12 December 2020

Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review

1 reference

12 December 2020

Effects of bromocriptine on neuroleptic-induced amenorrhea, galactorrhea and impotence

1 reference

12 December 2020

Phenothiazines and breast cancer.

1 reference

12 December 2020

Galactorrhea and hyperprolactinemia in schizophrenic patients on neuroleptics: frequency and etiology

1 reference

12 December 2020

Prolactin and murine mammary tumorigenesis: a review

1 reference

12 December 2020

Prolactin and related peptides in pregnancy

1 reference

12 December 2020

Prolactin levels and adverse events in patients treated with risperidone.

1 reference

12 December 2020

Tuberoinfundibular dopamine neurons and the regulation of prolactin secretion

1 reference

12 December 2020

High plasma prolactin levels after long-term neuroleptic treatment

1 reference

12 December 2020

Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study

1 reference

12 December 2020

Dopaminergic factors in human prolactin regulation: Effects of neuroleptics and dopamine☆

1 reference

12 December 2020

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder

1 reference

12 December 2020

Inhibition of lactation by a long-acting bromocriptine

1 reference

12 December 2020

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

1 reference

12 December 2020

Osteoporosis in women with anorexia nervosa

1 reference

12 December 2020

Review of recent clinical studies with olanzapine

1 reference

12 December 2020

Gynecomastia with sulpiride

1 reference

12 December 2020

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

12 December 2020

Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia

1 reference

12 December 2020

The dexamethasone suppression test in schizophrenia

1 reference

12 December 2020

Psychological distress in patients with hyperprolactinaemia.

1 reference

12 December 2020

Prolactin-dependent rat mammary cancer: a model for man?

1 reference

12 December 2020

Bromocriptine in Tardive Dyskinesia

1 reference

12 December 2020

Antipsychotic induced hyperprolactinaemia: a series of illustrative case reports

1 reference

12 December 2020

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

12 December 2020

The behavioral toxicity of bromocriptine in patients with psychiatric illness

1 reference

12 December 2020

The menstrual cycle and its disorders in psychiatric patients. II.

1 reference

12 December 2020

Effects of chlorpromazine on pituitary function.

1 reference

12 December 2020

Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.

1 reference

12 December 2020

Decreased bone density in hyperprolactinemic women

1 reference

12 December 2020

Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders

1 reference

12 December 2020

1 reference

12 December 2020

Risperidone and associated amenorrhea: a report of 5 cases.

1 reference

12 December 2020

Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries

1 reference

12 December 2020

The Effect of Neuroleptics on Serum Prolactin in Schizophrenic Patients

1 reference

12 December 2020

Schizophrenia and smoking: an epidemiological survey in a state hospital

1 reference

12 December 2020

Elevated prolactin in pediatric patients on typical and atypical antipsychotics.

1 reference

12 December 2020

Adverse effects of zotepine and their relationship to serum concentrations of the drug and prolactin

1 reference

12 December 2020

Prolactin and neuroleptic drugs

1 reference

12 December 2020

Diagnosis and management of pituitary tumours

1 reference

12 December 2020

The Effect of Amantadine on Prolactin Levels and Galactorrhea on Neuroleptic-Treated Patients*

1 reference

12 December 2020

The psychogenic effects of prolactin

1 reference

12 December 2020

Prolactin secretion in patients treated with various drugs: phenothiazines, tricyclic antidepressants, reserpine, and methyldopa.

1 reference

12 December 2020

The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis

1 reference

12 December 2020

Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine

1 reference

12 December 2020

Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response

1 reference

12 December 2020

Hyperprolactinemia and male sexual dysfunction

1 reference

12 December 2020

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group

1 reference

12 December 2020

Tolerance to the prolactin-elevating effect of neuroleptics

1 reference

12 December 2020

Reduced spinal and femoral bone mass and deranged bone mineral metabolism in chronic alcoholics

1 reference

12 December 2020

Prolactin concentrations in normal menstrual cycles and conception cycles

1 reference

12 December 2020

Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea

1 reference

12 December 2020

Sexual Dysfunction in Patients with Hypothalamo-Pituitary Disorders

1 reference

12 December 2020

Regional distribution of sultopride and sulpiride in rat brain measured by radioimmunoassay.

1 reference

12 December 2020

Subjective utility ratings of neuroleptics in treating schizophrenia

1 reference

12 December 2020

Relationship of gender and menstrual status to symptoms and medication side effects in patients with schizophrenia.

1 reference

12 December 2020

Osteoporosis in men with hyperprolactinemic hypogonadism

1 reference

12 December 2020

Correlation between prolactin response and therapeutic effects of zotepine in schizophrenic patients

1 reference

12 December 2020

Effects of chronic neuroleptic administration on the hypothalamo-pituitary-gonadal axis of male schizophrenics

1 reference

12 December 2020

In vivo labelling of pituitary dopamine D-2 receptors in the male rat using [3H]-raclopride

1 reference

12 December 2020

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

12 December 2020

Neuroendocrine pharmacology of serotonergic (5-HT) neurons

1 reference

12 December 2020

A pilot study of a structured interview addressing sexual function in men with schizophrenia

1 reference

12 December 2020

The bone density of female twins discordant for tobacco use

1 reference

12 December 2020

Sexual side effects of novel antipsychotic medications

1 reference

12 December 2020

Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice

1 reference

12 December 2020

Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients

1 reference

12 December 2020

Relation of Plasma Prolactin to Clinical Response in Schizophrenic Patients

1 reference

12 December 2020

Endocrinological Changes in Patients with Sexual Dysfunction under Long-Term Neuroleptic Treatment

1 reference

12 December 2020

Effect of gamma-aminobutyric acid on growth hormone and prolactin secretion in man: influence of pimozide and domperidone

1 reference

12 December 2020

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

1 reference

12 December 2020

Changes in bone density with lactation

1 reference

12 December 2020

Brom-ergocryptine in the Treatment of Phenothiazine-Induced Galactorrhoea

1 reference

12 December 2020

Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome

1 reference

12 December 2020

Interpreting prolactin levels: implications for the management of large pituitary lesions

1 reference

12 December 2020

Dopamine antagonists and the development of breast cancer

1 reference

12 December 2020

Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones, and cortisol in schizophrenia

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers

1 reference

12 December 2020

The risks of oral contraceptive pills

1 reference

12 December 2020

Circadian rhythm of free urinary cortisol, temperature and heart rate in endogenous depressives and under antidepressant therapy

1 reference

12 December 2020

Effect of clozapine on human serum prolactin levels

1 reference

12 December 2020

Direct inhibitory effect of long term estradiol treatment on dopamine synthesis in tuberoinfundibular dopaminergic neurons: in vitro studies using hypothalamic slices

1 reference

12 December 2020

Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia.

1 reference

12 December 2020

Sexual dysfunction in patients taking conventional antipsychotic medication

1 reference

12 December 2020

Effects of prolactin and estrogen deficiency in amenorrheic bone loss

1 reference

12 December 2020

A study of quetiapine: efficacy and tolerability in psychotic adolescents

1 reference

12 December 2020

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

12 December 2020

Effect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups

1 reference

12 December 2020

Prolactin: structure, function, and regulation of secretion

1 reference

12 December 2020

Are chronic psychiatric patients at increased risk for developing breast cancer?

1 reference

12 December 2020

Decreased bone mineral density in medicated psychiatric patients.

1 reference

12 December 2020

Neither gynecomastia nor galactorrhea is a common side effect of neuroleptics in male patients

1 reference

12 December 2020

A study of serum prolactin levels in schizophrenia: comparison of males and females

1 reference

12 December 2020

Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels

1 reference

12 December 2020

Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia

1 reference

12 December 2020

Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea

1 reference

12 December 2020

Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients

1 reference

12 December 2020

Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia.

1 reference

12 December 2020

Osteopenia, pathological fractures, and increased urinary calcium excretion in schizophrenic patients with polydipsia

1 reference

12 December 2020

Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone

1 reference

12 December 2020

Plasma prolactin and central D2 receptor occupancy in antipsychotic drug-treated patients.

1 reference

12 December 2020

Different expression of the two dopaminergic D2 receptors, D2415 and D2444, in two types of lactotroph each characterised by their response to dopamine, and modification of expression by sex steroids.

1 reference

12 December 2020

Effects of chronic sulpiride-induced hyperprolactinemia on menstrual cycles of normal women

1 reference

12 December 2020

The effects of phenothiazines on endocrine function: I. Patients with inappropriate lactation and amenorrhoea.

1 reference

12 December 2020

The physical consequences of depressive illness

1 reference

12 December 2020

Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone

1 reference

12 December 2020

Management of psychotropic-induced hyperprolactinemia

1 reference

12 December 2020

Serum prolactin concentration in patients taking neuroleptic drugs

1 reference

12 December 2020

Neuroendocrine response to antipsychotics: effects of drug type and gender.

1 reference

12 December 2020

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group

1 reference

12 December 2020

Increase in bone mass after treatment of hyperprolactinemic amenorrhea

1 reference

12 December 2020

Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia

1 reference

12 December 2020

Neurotransmitter regulation of anterior pituitary hormones

1 reference

12 December 2020

Clinical and neuroendocrine effects of zotepine--a new neuroleptic drug

1 reference

12 December 2020

10.2165/00003495-200464200-00003

Identifiers

DOI

1 reference

PubMed ID

15456328

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

15456328